TrialBiomaterials2021

Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm.

Yun Young Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.